Does GLP-1 Work for Weight Loss?

How Does GLP-1 Medication Work?

GLP-1 stands for glucagon-like peptide-1, a hormone released from the gut after eating. It signals fullness to the brain, slows gastric emptying, and regulates insulin. Medications known as GLP-1 receptor agonists—such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)—amplify this signal, making people feel satisfied with less food.

For many, the effect is profound. Hunger fades. Portions shrink naturally. The mental effort of managing intake decreases. During this phase, weight loss can be significant—sometimes 10-15% of body weight or more.

What GLP-1 Medications Do Not Train

GLP-1 medications suppress appetite. They do not, however, retrain the underlying eating behaviours that contributed to weight gain in the first place. The medication does not teach you:

• How to make food decisions when hunger returns
• How to navigate food environments full of starch and sugar
• How to eat under stress, fatigue, or social pressure
• How to establish routines that support lower-starch eating long-term

While appetite is reduced, these skill gaps often go unnoticed. The medication handles the heavy lifting. But the moment the medication stops—or its effect diminishes—those gaps become visible.

What Happens After the Medication Stops

Clinical data shows that most people who discontinue GLP-1 medications regain a significant portion of the weight they lost. In the STEP 1 extension trial, participants regained roughly two-thirds of lost weight within one year of stopping semaglutide. Similar trends have been observed across other GLP-1 trials.

This is not because the medication failed. During active treatment, it did exactly what it was designed to do: reduce hunger and support caloric deficit. The regain happens because when normal appetite signals return, so do the patterns and routines that led to weight gain originally.

What GLP-1 Does Not Solve

1. Eating Habits

Without deliberate practice, people return to familiar foods and portion sizes when appetite suppression ends. The habits were paused, not replaced.

2. Social and Cultural Pressure

Eating is embedded in social contexts—family dinners, work lunches, holidays. GLP-1 does not prepare people for navigating these situations once their appetite normalises.

3. Food Environment

Starch and sugar remain highly accessible. When hunger returns, so does the challenge of resisting foods that trigger rapid intake and blood sugar swings.

The Weight Permanence Training™ Solution

What determines long-term success is not the medication itself—it's what happens during and after. The Weight Permanence Training™ (WPT) is a neurobehavioural training framework designed to address exactly this.

WPT has three stages:

• Awareness – Recognising how specific foods trigger hunger and how routines shape eating patterns
• Practice – Building new behaviours through deliberate repetition in real-world contexts
• Permanence – Reaching the point where low-starch eating becomes automatic, no longer requiring willpower

When combined with GLP-1 medication, WPT transforms the window of appetite suppression into an opportunity to build lasting skills. Instead of coasting on reduced hunger, you actively train new defaults—so that when appetite returns, the foundation is already in place.